Johnstone, J. A., Ross, C. A. C., and Dunn, M. (1972) . Archives of Disease in Childhood, 47, 647. Meningitis and encephalitis associated with mumps infection: a 10-year survey. During the 10-year period 1960-69, 137 patients in Ruchill Hospital were diagnosed by clinical and laboratory findings as mumps meningitis. Parotitis was detected in only 51 (37%). There was a male preponderance, 97: 40. 960% of the males were under 10 years old compared with 78% of the females. The peak incidence of patients with meningitis alone was in June-July, parotitis with meningitis was from November to January. All 137 meningitis patients made a good recovery.
Of the 2 definite cases of mumps encephalitis 1 showed severe psychomotor sequelae.
More of the total 139 patients showed rising titres to mumps 'V' envelope antigen than to mumps 'S' nucleoprotein antigen.
Live attenuated mumps vaccines have been developed recently and used in the U.S.S.R. and U.S.A. (Hilleman et al., 1968) . The advisability of introducing a mumps vaccine for routine use in Britain has been questioned by Dick (1969) on the grounds that there are practically no data on the incidence of mumps or its complications on which to base a rational and logical immunization programme. He also claims that mumps is relatively mild in children and that serious sequelae appear to be rare.
The most common complication of mumps is aseptic meningitis; indeed mumps is the commonest perennial cause of aseptic meningitis in Britain. The most serious complication of mumps is encephalitis. It therefore seemed relevant to analyse our clinical and laboratory findings for mumps meningitis and encephalitis over the 10-year period . Also, since deafness sometimes foUows mumps infection (Fowler, 1960; Lindsay, Davey, and Ward, 1960; Whetnall and Fry, 1964) , a follow-up study to investigate hearing was attempted. In establishing a laboratory diagnosis of mumps infection serological demonstration of a rising antibody titre for mumps is more reliable than virus isolation, and the most practical serological method for mumps diagnosis is complementfixation (CF). During infection with mumps two distinct CF antibodies appear in the patient's blood, one against the envelope of the virus (anti-V) and the other against 'soluble' viral nucleoprotein (anti-S). In early convalescence the titre of both antibodies is high, but anti-S usually disappears within a few months whereas anti-V persists for many years (Henle, Harris, and Henle, 1948) .
Slight antigenic relation between mumps and parainfluenza viruses has been reported (Cook et al., 1959 since they all had pleocytosis in cerebrospinal fluid (CSF), they have been considered as cases of mumps meningitis. The remaining 2 with more severe evidence of cerebral involvement had residual neurological signs on discharge from hospital; in this study they have been considered as cases of mumps encephalitis (see below). One of these 2 showed normal CSF findings.
Meningitis cases. These comprised 137 patients in whom meningitis was confirmed by the presence of pleocytosis in CSF. Parotitis, the accepted clinical criterion of mumps infection, was detected in only 51 (37%) of the total 137 patients.
Thus, in most cases virological tests were necessary to establish the diagnosis. Rising antibody titres for mumps were obtained in 105 (73%) of the 137 patients: 68 for both S and V, 27 for V only, and 10 for S only (Table I ). In both groups more patients showed rising titres to the V than to the S antigen, more in Group M than in Group MP. Age, sex, and parotitis. Table II shows that of the total 137 patients 97 (71%) were males and 40 (29%) females, i.e. a male preponderance. Males seemed to acquire this illness earlier than females: 88 (96%) of the total 97 males being under 10 years old compared with 31 (78%) of the total 40 females. Only three patients (all females) were in the group 10-14 years old. Parotitis was also more frequently detected in the males: 45 (46 %) compared with 6 (15%) of the females; the male age-group showing the highest proportion of cases with parotitis was 5 to 9 years.
Month of illness. The cumulative number of cases with onset of illness by month is shown in Table III . Cases occurred in each month, but the peak incidence of Group M patients was in JuneJuly (34 (39 %) of the 86), whereas the peak of Group MP was from November to January (27 (53%) of the 51).
CSF examination. The range of the initial cell counts is shown in Table IV unconscious for almost 12 hours before admission to hospital, by which time bilateral facial swelling, particularly marked on the right side, had developed. He was reported to have injured his head 2 weeks before the onset of illness. Apart from pallor on the night of the injury, no abnormal signs had been noted. Cases of mumps were prevalent in his home area, some 130 miles from Glasgow. On admission the child was semicomatose and had marked meningismus. Jerky movements of all four limbs were frequent. The parotid glands were swollen and an erythematous rash was present on the face and limbs. Herpes lesions were found on the upper lip. His temperature was 37°C, pulse 138/min, respiration 28/min. CSF: cells 306/mm3, protein 40, and sugar 51 mg/100 ml. Temperature continued raised (maximum 38-2°C) during the first 5 days in hospital and the child remained semiconscious for the first 3 days. On 29 December, he was able to sit up though still showing some neck stiffness. Thereafter recovery was straightforward, but on discharge on 21 January 1961, his gait was clumsy. When reviewed in 1971, at the age of 16 years, he had no disability.
Mumps virus was isolated from the CSF taken on admission. Sera of 26 December 1960, and 6 January 1961, respectively, gave titres of 128 and 128 for mumps 'S', 128 and 512 for mumps 'V'.; all other serological tests were negative. No virus was isolated from faeces.
Discussion
In the present study both groups, i.e. patients with meningitis (Group M) and patients with meningitis and parotitis (Group MP), had more with rising CF titres to the V antigen than to the S antigen. Moreover, anti-V antibody usually appeared earlier in the illness than anti-S. This is not in keeping with the findings of Henle et al. (1948) (Grist et al., 1966) were not treated by these procedures.
Several previous workers have shown that mumps meningitis is generally benign with few sequelae (Afzelius-Alm, 1951; Russell and Donald, 1958 Only two definite cases of mumps encephalitis were observed during this 10-year period in Ruchill, one of whom had no signs of meningitis despite severe cerebral involvement. Further, it was of interest that the only child admitted to hospital with deafness associated with mumps infection during the period of this study had neither meningitis nor parotitis. Her mother noticed one day that the child was neither responding to the spoken word nor to sounds. The father, a doctor, sought otological opinion immediately and the diagnosis of severe, bilateral perceptive deafness was confirmed. This child showed no CSF abnormality. Serological tests on a single serum gave evidence of recent infection with mumps, antibody titres for mumps 'S' and mumps 'V' being 128 and 512 respectively. The child's two older male sibs were at this point recovering from clinical mumps. Further details of this case have already been described by one of us (Dunn, 1966) . The occurrence of encephalitis without meningitis has also been observed by previous workers (Miller, Stanton, and Gibbons, 1956 ). This suggests that mumps encephalitis may be caused by direct invasion of the central nervous system from the nasopharynx, as suggested for herpes simplex encephalitis by the studies of Johnson (1964) . It would also be in keeping with the suggestion of several previous workers (Russell and Donald, 1958) that mumps virus is primarily neurotropic and that involvement of the parotid glands occurs as a secondary and not invariable complication. Miller et al. (1956) collected data on 27 cases of so-called 'mumps encephalomyelitis' reported since 1934. Of these, 6 had died; of the 21 survivors, 9 recovered fully, 5 had minor sequelae, and 7 had major sequelae. From these findings and from the present study it seems that mumps meningitis is a benign complication of mumps infection, but that encephalitis sometimes without evidence of meningitis, has a much graver prognosis. The term 'meningoencephalitis' should therefore be used with caution. The rarity of severe neurological involvement in mumps infection lends no support to the routine use of mumps vaccine in Britain.
The reason for the preponderance of males over females with mumps meningitis, and the earlier age of mumps meningitis in males than in females, is unknown. It may be that males and females are equally liable to mumps infection but that females may have more subclinical infections. In the present study the marked excess of parotitis in the males with meningitis as compared with the females suggests that in mumps infection a sex-linked genetic or hormone-mediated mechanism may be concerned in parotid enlargement. On the other hand, the greater prevalence of parotitis accompanying meningitis in males during the winter months suggests that development of clinical parotitis may be associated with colder temperatures (with the possibility that thicker subcutaneous fat in females may maintain higher temperatures in parotid tissues) or with some weather-related factor such as respiratory virus infections.
